Notably, most C.3 tumors (8/9 cases) were IDH-mutant GBMs (grade IV), including six recurrent tumors and two de novo GBMs, which are generally considered to have progressed from lower-grade astrocytomas (Supplementary Table S2). This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).